GURU.Markets stock price, segment price, and overall market index valuation
The company's share price FEMY
Femasys is a women's health company. Its stock price is a bet on its innovative contraceptive and diagnostic products. The chart reflects high volatility and dependence on regulatory approvals and commercial success.
Share prices of companies in the market segment - Medical instruments
Femasys Inc. is a medical device company developing innovative solutions for women's health, including contraception and infertility diagnostics. We've categorized it as a "Medical Instruments" company. The chart below shows how investors view the FemTech (female technology) sector.
Broad Market Index - GURU.Markets
Femasys is a medical company developing innovative products for women's health, including infertility diagnostics and treatment. As a unique player, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with Femasys' performance to assess the state of the sector.
Change in the price of a company, segment, and market as a whole per day
FEMY - Daily change in the company's share price FEMY
Femasys Inc.'s daily stock price fluctuations reflect the volatility of the women's healthcare technology sector. The metric demonstrates sensitivity to news about the commercialization of its products and regulatory approvals.
Daily change in the price of a set of shares in a market segment - Medical instruments
Femasys Inc. is a medical device company. This chart illustrates the high volatility of the MedTech industry. Comparing it to FEMY, which focuses on women's health, helps us understand how its innovative products contribute to its volatility.
Daily change in the price of a broad market stock, index - GURU.Markets
Femasys is a healthcare company focused on women's health. Its shares are highly volatile and depend on the success of its product commercialization and clinical trial results. These scientifically based movements are part of the complex picture of the overall stock market.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization FEMY
Femasys Inc.'s year-over-year performance is a story of developing innovative solutions for women's health. Its 12-month market cap depends entirely on progress in commercializing its contraceptive and diagnostic products. Successful implementation of its technologies in gynecological practice is fundamental to its future.
Annual dynamics of market capitalization of the market segment - Medical instruments
Femasys Inc. is a commercial medical device company focused on women's health. The chart shows how its innovative yet niche products and market expansion efforts impact its performance compared to major medical device manufacturers.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Femasys, a manufacturer of women's health medical devices, demonstrates its dynamic journey from innovation to commercial success. Its performance, relative to the market, reflects investors' assessment of the potential of its products and the company's ability to secure regulatory approval and convince physicians of their value.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization FEMY
Femasys is a company specializing in women's health. Its monthly performance is driven by progress in the commercialization of its contraceptive and diagnostic products. News of its interactions with the FDA and sales growth are the main drivers of its value.
Monthly dynamics of market capitalization of the market segment - Medical instruments
Femasys is a biomedical company focused on women's health. They develop innovative and less invasive solutions for reproductive medicine and contraception. The graph below shows the overall dynamics in the medical devices sector, reflecting the growing demand for technologies tailored to the specific needs of women.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Women's health stocks can be defensive, but they're also growth stocks. The chart below shows the overall sentiment. What's more influential on Femasys: sector stability or growth stock volatility?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization FEMY
Femasys develops medical devices for women's health. Its weekly stock price reflects progress in clinical trials, FDA approvals, and the commercial potential of its innovative products in this important medical niche.
Weekly dynamics of market capitalization of the market segment - Medical instruments
Femasys shares, like many companies in the medical devices sector, can be volatile. This chart helps distinguish unique movements related to the company's product news from the general market tide sweeping the entire industry. Does the company react to news more strongly or less strongly than its competitors?
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Femasys Inc., as a medical technology company, should be less dependent on economic cycles. The chart will show how insulated the company's shares are from general market fluctuations, moving with product news and regulatory decisions while ignoring macroeconomic noise.
Market capitalization of the company, segment and market as a whole
FEMY - Market capitalization of the company FEMY
The Femasys Inc. chart is a bet on innovation in women's health. Its market cap reflects investors' faith in the company's portfolio of medical products designed for reproductive medicine. Its performance reflects how the market perceives the commercial potential of its unique technologies in this niche.
FEMY - Share of the company's market capitalization FEMY within the market segment - Medical instruments
Femasys develops and markets medical devices for women's health. Its market capitalization in this segment reflects its focus on solving specific medical problems often ignored by large manufacturers. The company's market share reflects the extent to which its innovative products are in demand by gynecologists and their potential to improve patients' quality of life.
Market capitalization of the market segment - Medical instruments
Femasys develops innovative solutions for women's health. How big is this industry? The chart below shows the overall market capitalization of the medical instrument sector. Its steady growth reflects the ongoing demand for new, more gentle, and effective technologies in gynecology and reproductive medicine.
Market capitalization of all companies included in a broad market index - GURU.Markets
The Femasys chart shows how the market values innovations in women's health. The valuation of the company, which develops less invasive contraceptive and diagnostic devices, is a venture bet on its ability to change standards in gynecology. This chart is full of medical and commercial risks.
Book value capitalization of the company, segment and market as a whole
FEMY - Book value capitalization of the company FEMY
For Femasys, a women's health company, book value is its medical device manufacturing facilities and R&D centers. This is the material foundation of its specialized medical business. The chart below shows how the company has grown its production and intellectual capital.
FEMY - Share of the company's book capitalization FEMY within the market segment - Medical instruments
Femasys Inc. creates innovative solutions for women's health. Its tangible assets are the manufacturing facilities where its unique medical instruments are created. These assembly lines are the physical source of new standards in gynecology. The chart shows the share of this niche medical manufacturing infrastructure the company controls.
Market segment balance sheet capitalization - Medical instruments
Femasys is a medical technology company. This sector, as the chart shows, is capital-intensive. Femasys uses a balanced model. It invests in R&D and production of its unique devices, but also utilizes contract manufacturing.
Book value of all companies included in the broad market index - GURU.Markets
Femasys' assets are not drugs, but rather production facilities and development centers for the creation of innovative medical devices for women's health, offering alternatives to traditional procedures. Its book value reflects its industrial and technological potential in this important medical niche.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - FEMY
Femasys develops medical devices for women's health. The company has no significant tangible assets. Its market capitalization is the valuation of its innovative products and patents. The chart shows how investors assess its potential to change standards in areas such as contraception and infertility diagnostics.
Market to book capitalization ratio in a market segment - Medical instruments
Femasys develops and markets medical devices for women's health. It's an innovative business where patents and technology play a key role. The chart shows the market premium for its unique products and intellectual property compared to the book value of its assets.
Market to book capitalization ratio for the market as a whole
Femasys develops medical devices for women's health. Patents for unique devices and regulatory approvals are its core assets, not its production capacity. This chart illustrates how investors evaluate the potential of patented medical technologies compared to the assets of companies in other sectors.
Debts of the company, segment and market as a whole
FEMY - Company debts FEMY
Femasys is a medical technology company focused on women's health. Developing, obtaining approvals, and bringing new medical devices to market is a capital-intensive process. Debt financing can be part of a strategy to ensure the continuity of clinical research and prepare for the commercial launch of its innovative products.
Market segment debts - Medical instruments
Femasys is a company developing medical devices for women's health. Commercializing new medical products requires significant investment in clinical trials, regulatory approvals, and marketing. This chart shows how the company finances this lengthy and costly process to market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio FEMY
Femasys develops medical devices for women's health. This chart shows its financial structure. For a company bringing new products to market, it's important to have a solid financial foundation. Debt can become a significant obstacle if regulatory approvals and commercialization are delayed and cash flow is negative.
Market segment debt to market segment book capitalization - Medical instruments
Femasys develops medical devices for women's health, offering innovative solutions in contraception and diagnostics. This market requires regulatory approval and clinical data. The chart shows the overall debt burden in the sector, which helps assess how Femasys finances its expensive R&D and preparation for market entry.
Debt to book value of all companies in the market
Femasys Inc. develops medical devices for women's health. During the commercialization phase of its products, the company incurs significant marketing and manufacturing expenses. This chart shows general financing terms, which helps understand which financing route—debt or equity—is most accessible and feasible for Femasys.
P/E of the company, segment and market as a whole
P/E - FEMY
This chart shows the valuation of Femasys, a company developing medical devices for women's health. The P/E (when positive) will reflect the success of its products in the market and its ability to secure regulatory approval. This is an assessment of the commercial potential of its innovative solutions in its medical niche.
P/E of the market segment - Medical instruments
Femasys is a biomedical company specializing in the development and commercialization of innovative solutions for women's health, including contraception and infertility diagnostics. This chart shows the average rating for medical device manufacturers, helping to understand how the market values this women's health-focused company.
P/E of the market as a whole
Femasys is a company developing medical devices for women's health. Its valuation depends on the success of its innovative products and their implementation in clinical practice. General economic cycles, reflected in this chart, have little impact on demand for its products, which is driven by medical needs. For Femasys, the decisions of regulators and physicians are more important.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company FEMY
Femasys is a women's health company developing innovative gynecological medical devices. This chart reflects investor expectations regarding the commercialization of its contraceptive and infertility diagnostic products. The valuation is based on the potential of its technologies to change the standard of care in this niche.
%20P%2FE%20FEMY&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-FEMY&v=1772570181229 "Chart of the company's future (projected) P/E FEMY")
Future (projected) P/E of the market segment - Medical instruments
Femasys develops medical devices for women's health. Its valuation relative to other companies in the medical device sector reflects investor expectations for its innovative products. This demonstrates the market's confidence in its ability to change the standard of care in gynecology and successfully commercialize its developments.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Medical-instruments&v=1772570181311 "Future (projected) P/E graph of the market segment - Medical instruments")
Future (projected) P/E of the market as a whole
Femasys develops and commercializes medical devices for women's health. This is a niche market dependent on the adoption of new technologies in clinical practice. This chart shows the overall sentiment in the healthcare sector and investor risk appetite. It helps assess how the market perceives innovative, but not yet widely available, medical products.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772570181364 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit FEMY
Femasys is a medical device company focused on women's health, with a focus on reproductive and gynecological solutions. The financial results illustrated in this chart depend on the successful commercialization of its innovative products and their acceptance by the medical community.
Profit of companies in the market segment - Medical instruments
Femasys Inc. develops medical instruments focused on women's health, offering innovative solutions for gynecology. This chart shows the overall profitability of the medical instruments sector. It helps assess the market's readiness to embrace new technologies in this field and how this impacts the profitability of niche manufacturers.
Overall market profit
Femasys develops and commercializes medical devices for women's health. Demand for its products is driven more by demographic trends, innovation, and the acceptance of its technologies by the medical community than by general economic cycles. This dynamic has little impact on the need to address the specific medical problems FEMY focuses on.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company FEMY
Femasys develops medical devices for women's health, offering innovative solutions in contraception and diagnostics. The company's future revenue depends on regulatory approval and acceptance of its products by the medical community. This chart reflects analyst expectations for the commercial potential of its unique developments.
%20profit%20of%20the%20company%20FEMY&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-FEMY&v=1772570181473 "Graph of future (projected) profit of the company FEMY")
Future (predicted) profit of companies in the market segment - Medical instruments
Femasys is a women's health company developing minimally invasive medical devices for contraception and infertility treatment. This chart shows forecasts for the medical devices sector. It helps assess the growth potential of Femasys' innovative products aimed at improving women's quality of life, compared to overall industry expectations.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Medical-instruments&v=1772570181488 "Graph of future (predicted) profits of companies in a market segment - Medical instruments")
Future (predicted) profit of the market as a whole
The overall economic backdrop, reflected in the chart, influences the financing of companies in the medical equipment sector. Femasys, which develops women's health solutions, needs investment to bring its products to market. Economic growth facilitates raising capital, while a recession complicates this process.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772570181528 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - FEMY
Femasys develops medical devices for women's health. This chart shows the premium investors are willing to pay for its early revenue. This is a bet that its innovative products will find widespread adoption and capture a significant share of the medical device market.
P/S market segment - Medical instruments
Femasys is a women's health company developing innovative medical devices for gynecology. This chart shows the average valuation in the medical devices sector. It helps understand the premium investors are willing to pay for Femasys' products, which are designed to improve diagnostic and treatment procedures in the doctor's office, compared to the industry.
P/S of the market as a whole
Femasys Inc. is a women's health company developing and commercializing minimally invasive medical devices. Revenue depends on the adoption of its products in gynecological practice. This chart provides an overview of how the market views innovation in a highly specialized medical niche against the backdrop of overall trends.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company FEMY
Femasys develops medical devices for women's health. The company's future revenue depends on regulatory approvals and the successful commercialization of its innovative products. This chart shows how the market perceives the potential sales volume of its devices and its ability to carve out a niche in the medical technology sector.
%20P%2FS%20FEMY&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-FEMY&v=1772570181771 "The graph of the company's future (projected) P/S FEMY")
Future (projected) P/S of the market segment - Medical instruments
Femasys Inc. develops and commercializes medical devices for women's health, offering minimally invasive solutions for contraception and infertility diagnostics. The company aims to modernize gynecological practice. This chart shows how investors assess the sales potential of its innovative products compared to other medical device manufacturers.
%20P%2FS%20market%20segment%20graph%20-%20Medical%20instruments&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Medical-instruments&v=1772570181821 "Future (projected) P/S market segment graph - Medical instruments")
Future (projected) P/S of the market as a whole
This reflects investors' faith in innovation in women's health. For Femasys, a company developing medical instruments for gynecology, this is an indicator of the market's appetite for new technologies. Investor optimism helps fund the development and commercialization of products aimed at improving diagnostics and treatment.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772570181869 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales FEMY
Femasys is a biomedical company focused on developing innovative solutions for women's health, including infertility diagnostics and treatment, as well as permanent contraception. This graph will reflect revenue from sales of its products after their commercialization. Growth will reflect acceptance of its technologies by doctors and patients.
Sales of companies in the market segment - Medical instruments
Femasys Inc. develops and commercializes innovative medical devices for women's health. This chart shows the growth of the medical device market. Femasys focuses on creating less invasive and more accessible diagnostic and treatment solutions, reflecting the overall trend toward improving the quality of gynecological care.
Overall market sales
Femasys Inc. develops medical instruments for women's health. Demand for its products depends on healthcare budgets and patient access to procedures. The overall economic situation, reflected in this graph, influences healthcare spending and clinics' willingness to implement innovative medical technologies.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company FEMY
Femasys Inc. is a company developing medical devices for women's health, including contraception and infertility diagnostic solutions. Future sales are dependent on regulatory approval and the introduction of its products into gynecological practice. This chart shows analysts' forecasts for the commercial potential of Femasys' innovative solutions.
%20sales%20of%20the%20company%20FEMY&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-FEMY&v=1772570182403 "Schedule of future (projected) sales of the company FEMY")
Future (projected) sales of companies in the market segment - Medical instruments
Femasys is a company developing medical instruments for women's health. This chart illustrates expectations for the entire medical equipment industry. It helps understand the growth analysts anticipate in demand for innovative solutions in gynecology and reproductive medicine, which is important for assessing Femasys' market niche.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Medical-instruments&v=1772570182626 "Schedule of future (projected) sales of companies in the market segment - Medical instruments")
Future (projected) sales of the market as a whole
Femasys Inc. is a women's health company developing innovative medical devices for gynecology. Its commercial success depends on the implementation of new technologies in clinical practice. This graph, reflecting the overall state of the economy, influences the budgets of medical institutions and their willingness to purchase new, more advanced equipment.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772570182664 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality FEMY
Femasys develops and markets medical devices for women's health. This chart reflects the company's financial performance at the commercialization stage. Profitability depends on the successful implementation of its innovative solutions in clinical practice, which requires significant marketing and physician training.
Market segment marginality - Medical instruments
Femasys develops and manufactures medical devices for women's health. In this niche, profitability is determined by product innovation and the effectiveness of their launch. This chart shows the average profitability for medical device manufacturers, providing an insight into Femasys' commercial potential and operational acumen.
Market marginality as a whole
Femasys develops innovative medical tools for women's health. This overall market profitability figure is not key to the company's success. The company's success depends on physician acceptance of its technologies, regulatory approval, and demonstrating advantages over existing procedures. Its market is driven by medical need, not economic conditions.
Employees in the company, segment and market as a whole
Number of employees in the company FEMY
Femasys is a company developing medical devices for women's health. The chart shows a small but focused team of engineers, clinicians, and commercial specialists. Their number reflects the company's stage of development: from research and development to market entry and commercialization.
Share of the company's employees FEMY within the market segment - Medical instruments
Femasys develops innovative medical devices for women's health. This chart shows the percentage of biomedical engineers and clinical specialists the company attracts in this narrow and important field of medical technology. It reflects its concentration of expertise and talent focused on creating new solutions for reproductive medicine.
Number of employees in the market segment - Medical instruments
Femasys Inc. is a women's health company developing innovative medical devices for contraception and diagnostics. This important, yet often undervalued, sector of medicine requires a unique approach. This graph illustrates how medtech is creating new solutions that require engineers and doctors to be highly specialized in specific areas.
Number of employees in the market as a whole
Femasys develops medical instruments, advancing healthcare. This chart illustrates the overall employment landscape, with the medical technology sector being one of the most stable and fastest-growing. Femasys' innovations not only improve quality of life but also create demand for highly qualified engineers and clinicians.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company FEMY (FEMY)
Femasys is a company specializing in women's health medical devices. This chart reflects the high value of intellectual capital in the MedTech sector. The company's value is based not on mass production, but on its unique patented products (e.g., contraception and diagnostics). The chart shows how highly the market values this IP portfolio.
%20of%20the%20company%20FEMY%20(FEMY)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-FEMY-FEMY&v=1772570182895 "Chart of market capitalization per employee (in thousands of dollars) of the company FEMY (FEMY)")
Market capitalization per employee (in thousands of dollars) in the market segment - Medical instruments
Femasys develops and manufactures medical instruments for women's health. Success in this field depends on the innovation of its engineers and the quality of its production staff. This metric demonstrates the value the market places on each employee. This allows us to assess whether Femasys' product line is considered more promising than that of its competitors in the medical equipment sector.
%20by%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Medical-instruments&v=1772570182905 "Market capitalization per employee (in thousands of dollars) by market segment - Medical instruments")
Market capitalization per employee (in thousands of dollars) for the overall market
Femasys Inc. is a medical device company focused on women's health. This chart shows the market-wide performance rating of one employee. This provides insight into how the market values a company with innovative products in a specialized medical niche.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772570182966 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company FEMY (FEMY)
Femasys is a company that produces medical devices for women's health. They have commercial products. This graph shows how effectively their sales and production teams generate profit. It reflects the profitability of their patented devices and the success of their commercial strategy.
%20Chart%20FEMY%20(FEMY)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-FEMY-FEMY&v=1772570183031 "Company Profit Per Employee (in thousands of dollars) Chart FEMY (FEMY)")
Profit per employee (in thousands of dollars) in the market segment - Medical instruments
Femasys develops and markets innovative medical devices for women's health. The company's business requires significant investment in R&D and a dedicated team of engineers and marketers. This chart shows how effectively the company converts its intellectual and commercial efforts into financial results per employee, a key metric for companies in the medical technology sector.
%20in%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Medical-instruments&v=1772570183124 "Chart of profit per employee (in thousands of dollars) in the market segment - Medical instruments")
Profit per employee (in thousands of dollars) for the market as a whole
Femasys (FEMY) is a MedTech company specializing in the development of minimally invasive products for women's health (contraception, infertility diagnostics). This company focuses on R&D and commercialization of medical equipment. This chart provides a market-average breakdown of labor efficiency. It allows one to assess how effective FEMY's IP-based MedTech model is in generating revenue per employee (engineer, salesperson).
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772570183210 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee FEMY (FEMY)
Femasys develops medical instruments for women's health. This chart shows the commercialization of medical technology innovations. Growth in this indicator will indicate that the company's products are gaining acceptance among doctors, and the sales team is successfully bringing them to market, turning R&D into a stable revenue stream.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-FEMY-FEMY&v=1772570183222 "Sales chart per company employee FEMY (FEMY)")
Sales per employee in the market segment - Medical instruments
Femasys is a medical technology company focused on women's health and reproductive technologies. This chart shows the average revenue per employee in this segment. For a company commercializing its medical devices, it allows one to evaluate how productive its team (R&D, sales) is compared to other medical equipment manufacturers.
Sales per employee for the market as a whole
Femasys is a women's health company developing and commercializing medical devices. They have approved products. This chart shows how productive their team is. For a medtech company, this reflects the effectiveness of their R&D and, more importantly, their sales team in promoting their niche products to doctors and clinics.
Short shares by company, segment and market as a whole
Shares shorted by company FEMY (FEMY)
Femasys is a company developing medical devices for women's health, including non-surgical contraception and infertility diagnostics. This market requires lengthy and expensive clinical trials. This chart shows the number of investors betting the company will run out of money before it can commercialize its products.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-FEMY-FEMY&v=1772570183752 "Short Shares Chart for the Company FEMY (FEMY)")
Shares shorted by market segment - Medical instruments
Femasys Inc. is a biomedical company focused on women's health. They develop non-surgical and minimally invasive solutions for contraception and infertility treatment. This chart shows a general short position in the medical devices sector. Its rise may signal investor concerns about the lengthy FDA approval process or difficulties with commercialization in this niche.
Shares shorted by the overall market
Femasys develops medical equipment for women's health (contraception, infertility). This chart illustrates the overall market pessimism. Investors fear that during the crisis, non-emergency procedures (such as those related to fertility) will be postponed by patients, which will hurt Femasys' equipment sales.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator FEMY (FEMY)
This chart for Femasys is an indicator of demand for innovations in women's health. The company develops medical devices for contraception and infertility diagnostics. "Overbought" levels (above 70) arise from positive clinical trial data or regulatory approvals. Slow adoption of new procedures by doctors and competition from pharmaceuticals lead to "oversold" levels.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-FEMY-FEMY&v=1772570183943 "RSI 14 indicator chart for the company's stock FEMY (FEMY)")
RSI 14 Market Segment - Medical instruments
Femasys (FEMY) is "medtech" for *women*. Their focus is *minimally invasive* devices for *reproductive* health (contraception, infertility). The "Medical Instruments" (medtech) sector thrives on R&D. RSI_14_Seg shows whether the *entire* sector is "overbought." This helps differentiate: is FEMY's growth a niche or a general "overheating"?
RSI 14 for the overall market
Femasys (FEMY), a medical equipment manufacturer. This chart reflects hospitals' willingness to implement expensive innovations. During periods of euphoria and budget increases, clinics eagerly purchase new technologies. During times of panic and cost-cutting, they may postpone FEMY implementation in favor of cheaper, standard methods.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast FEMY (FEMY)
Femasys (FEMY) is a healthcare company developing innovative solutions for women's health, including non-surgical contraception and infertility diagnostics. This chart shows the average target price, reflecting analysts' confidence in the commercial potential of its niche products.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-FEMY-FEMY&v=1772570184075 "A chart showing analyst consensus forecasts for the expected stock price. FEMY (FEMY)")
The difference between the consensus estimate and the actual stock price FEMY (FEMY)
Femasys is a medtech company focused on women's health. It develops innovative non-surgical products for contraception and infertility diagnostics. This chart shows the difference between the market valuation and the consensus forecast. It reveals whether experts believe these niche but important medical devices will be adopted.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-FEMY-FEMY&v=1772570184090 "A chart showing the difference between the consensus forecast and the actual stock price. FEMY (FEMY)")
Analyst consensus forecast for stock prices by market segment - Medical instruments
Femasys is a MedTech company focused exclusively on women's health. It develops innovative devices for contraception and infertility treatment. This chart displays analysts' overall expectations for the medical devices sector. It shows whether experts believe in the growth of the "FemTech" niche (technologies for women).
Analysts' consensus forecast for the overall market share price
Femasys is a medical company focused on developing innovative women's health products (contraception, infertility diagnostics). This chart shows the overall risk appetite in the market. For Femasys, a company in the commercialization stage, overall market optimism (as shown by the rising chart) is important for raising the capital needed to bring its products to market.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index FEMY
Femasys is a MedTech company focused on women's health. Their specialty is R&D of non-surgical contraception and infertility solutions that can be performed right in the doctor's office. This chart is a pure indicator of their R&D. It doesn't reflect revenue, but rather a speculative estimate of their (very risky) pipeline and their chances of FDA approval.
AKIMA Market Segment Index - Medical instruments
Femasys (FEMY) is a medical device company focused on women's health. They produce diagnostic and therapeutic products for infertility and contraception (FemVue, FemCerv). The chart shows the average index for the segment, helping investors assess the relevance of this niche company compared to the average.
The AKIM Index for the overall market
Femasys is a MedTech company developing solutions for women's health, including non-surgical permanent contraception (FemBloc) and infertility diagnostics. This chart, reflecting the market average, provides context. It helps assess how this innovative approach, aimed at gynecological office procedures, compares to overall macroeconomic trends.
